Filing Details
- Accession Number:
- 0001441844-11-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-24 10:07:26
- Reporting Period:
- 2011-06-22
- Filing Date:
- 2011-06-24
- Accepted Time:
- 2011-06-24 10:07:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1331438 | Robert Mark Baker | 777 Old Saw Mill River Road Tarrytown NY 10591 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-06-22 | 490 | $7.08 | 31,922 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.